Test Price
2,800 AED✅ Home Collection Available
ACSL4 Gene X-linked Intellectual Disability Type 63 (MRX63) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
99.9% diagnostic sensitivity via ISO-accredited NGS. UAE home collection 8 AM–11 PM. Post-test telephonic clinical guidance. Direct insurance billing verification via WhatsApp +971 54 548 8731.
Core Metrics: Price: 2,800 AED | Turnaround: 3–4 weeks | Sample: Peripheral blood | Methodology: Next-generation sequencing (full gene coverage)
Test Overview & Methodology
The ACSL4 gene NGS test detects pathogenic variants in the ACSL4 gene, the established cause of X-linked intellectual disability type 63 (MRX63). This definitive molecular analysis clarifies the etiology of unexplained developmental delay and guides personalized management and family planning.
| Feature | Our Test (DHA-licensed) | Closest Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with full gene coverage | Limited gene panel / Sanger sequencing of selected exons |
| Analytical Sensitivity | 99.9% for single nucleotide variants and small indels | Variable; may miss deep intronic or regulatory mutations |
| Turnaround Time | 3–4 weeks | 4–6 weeks or longer |
| Pre-test Genetic Counseling | Included (pedigree analysis & risk assessment) | Often not included |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) notes: “A genetic diagnosis of MRX63 provides a clear biological explanation for developmental challenges, enabling tailored therapies and informed family planning. All results must be interpreted alongside a thorough clinical and developmental assessment.”
Exclusion Criteria & Emergency Red Flags
- Not indicated for acute neurological emergencies; seek immediate hospital care if the patient experiences new-onset seizures, loss of consciousness, or severe behavioral regression.
- Individuals under 18 years must have a legal guardian’s consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- This test requires a pre-test genetic counselling session; samples submitted without counselling will be delayed.
- If you suspect a life-threatening condition, call 998 for ambulance services immediately.
Patient FAQ & Clinical Guidance
1. What is the ACSL4 gene test for MRX63?
The ACSL4 gene test identifies mutations causing X-linked intellectual disability type 63, providing a definitive molecular diagnosis for affected males. It differentiates between various genetic causes of intellectual disability and guides accurate family genetic counseling.
2. Who should consider this genetic test?
This test is indicated for males with intellectual disability of unknown cause and suspected X-linked inheritance. It is also useful for assessing potential female carriers in families with a known or suspected ACSL4 mutation.
3. How is the test performed and what is the turnaround time?
A blood sample is collected from home by a certified phlebotomist. The sample undergoes next-generation sequencing analysis, with results available in 3–4 weeks. A detailed interpretative report and telephonic genetic counseling are provided.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Privacy
This service is governed by Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic information is processed exclusively within the UAE under our ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | ACSL4 Gene X-linked Intellectual Disability Type 63 (MRX63) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with full gene coverage |
| ICD-10-CM Code | F78 |
| LOINC Code | 101143-9 |
| DHA Facility License & Laboratory Address | License 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians